Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma: Technology appraisal guidance [TA524] – NICE

Evidence-based recommendations on brentuximab vedotin (Adcetris) for treating CD30-positive Hodgkin lymphoma in adults. This guidance is a Cancer Drugs Fund reconsideration of brentuximab vedotin for treating CD30-positive Hodgkin lymphoma (TA446). This guidance replaces TA446.  

Arsenic trioxide for treating acute promyelocytic leukaemia: Technology appraisal guidance [TA526] – NICE

Evidence-based recommendations on arsenic trioxide (Trisenox) for treating acute promyelocytic leukaemia in adults.  

Midostaurin for untreated acute myeloid leukaemia: Technology appraisal guidance [TA523] – NICE

Evidence-based recommendations on midostaurin (Rydapt) for untreated FLT3-mutation-positive acute myeloid leukaemia in adults.

Screening Quality Assurance visit report: NHS Cervical Screening Programme East Lancashire Hospitals NHS Trust – Public Health England

Finds the service is well organised with the lead colposcopist providing strong leadership. Team members are engaged and motivated. A systematic and focused approach to quality improvement was evident with engagement in activities to reduce health inequalities and improve community engagement to

Patient access to ibrutinib for previously treated chronic lymphocytic leukaemia in England – NHS England

This clinical statement gives details about patient access to ibrutinib for chronic lymphocytic leukaemia. It states NHS is funding the cancer drug in line with NICE recommendations.

National Dose Banding Table – Ipilimumab 5mgmL – NHS England

The national dose banding tables are to be used by hospital trust pharmacy teams to ensure a standard approach to dose banding of chemotherapy across all hospital trusts.

National Dose Banding Table – Capecitabine – NHS England

The national dose banding tables are to be used by hospital trust pharmacy teams to ensure a standard approach to dose banding of chemotherapy across all hospital trusts.

Screening Quality Assurance visit report: NHS Cervical Screening Programme Frimley Health NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Frimley Health NHS Foundation Trust held on 9, 19 and 20 June 2017. The QA visit team identified 2 immediate concerns which were addressed within seven days of the visit. all colposcopy examinations must

The Hidden Cancer: The Need to Improve Blood Cancer Care – All-Parliamentary Group on Blood Cancer

All-Parliamentary Group on Blood Cancer report that makes important recommendations on how to make improvements and ensure that we all work together to raise awareness of blood cancer. It is also a call to the Government and NHS to ensure

Lenvatinib with everolimus for previously treated advanced renal cell carcinoma: Technology appraisal guidance [TA498] – NICE

Evidence-based recommendations on lenvatinib (Kisplyx) with everolimus for previously treated advanced renal cell carcinoma in adults.

Ceritinib for untreated ALK-positive non-small-cell lung cancer: Technology appraisal guidance [TA500] – NICE

Evidence-based recommendations on ceritinib (Zykadia) for untreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer in adults.

Screening Quality Assurance visit report NHS Bowel Cancer Screening Programme: North East London Bowel Cancer Screening Centre

Executive summary of quality assurance (QA) visit to North East London Bowel Cancer Screening Centre held on 17 March 2017.  The QA visit team identified 9 high priority findings as summarised below: Barts Health NHS Trust does not have an agreed

Cancer in Kent and Medway – Public Health England

Kent and Medway Cancer Alliance Report that aims to give care providers and policy makers an insight into the burden of cancer – measured in terms of the number of people affected, deaths and survival. They also comment on some

Cancer in Thames Valley – Public Health England

Thames Valley Cancer Alliance Report that aims to give care providers and policy makers an insight into the burden of cancer – measured in terms of the number of people affected, deaths and survival. They also comment on some identified

Cancer in Surrey and Sussex – Public Health England

Surrey And Sussex Cancer Alliance Report that aims to give care providers and policy makers an insight into the burden of cancer – measured in terms of the number of people affected, deaths and survival. They also comment on some

Cancer in Wessex – Public Health England

Wessex Cancer Alliance Report that aims to give care providers and policy makers an insight into the burden of cancer – measured in terms of the number of people affected, deaths and survival. They also comment on some identified risk

Reducing avoidable hospital based care: re-thinking out of hospital clinical pathways – South East Clinical Senate

Improving health outcomes, preventing serious illness, providing convenient, timely and cost effective care, and avoiding the unnecessary use of acute hospitals, is a shared goal across the NHS, and requires a radical re-think about how and where care is delivered,

Lung cancer clinical outcomes publication 2017 (for surgical operations performed in 2015) – Royal College of Physicians and The Society for Cardiothoracic Surgery in Great Britain and Ireland

The clinical outcomes publication is an NHS England initiative, commissioned by the Healthcare Quality Improvement Partnership (HQIP), to publish quality measures at unit level and the level of individual consultant doctor using national clinical audit and administrative data. The following

National Prostate Cancer Audit: Annual Report 2017 Results of the NPCA Prospective Audit in England and Wales for men diagnosed from 1 April 2015 – 31 March 2016 – National Prostate Cancer Audit

National Prostate Cancer Audit annual report presenting national demographic information on patients diagnosed with prostate cancer, key aspects of the diagnostic and staging process they underwent and treatments received.  It describes variation in disease presentation across providers and presents performance

NHS efficiency map: redesigning services: Enhanced supportive cancer care – Healthcare Financial Management Association

Case study of the transformation of existing palliative care services into enhanced supportive care (ESC). . The multi-disciplinary ESC team covered all patients’ needs. It had strong financial support and worked with the oncology team, so that patients could access the ESC team at any stage